Dr. Laszlo SAJTI, graduated as a physicist in 2004 from the University of Szeged in Hungary, received PhD in 2007 in material sciences from the University of the Mediterranean Aix-Marseille in France, post-doctoral fellow between 2008-2009 with the excellence initiative of the Australian Federal Government in the Australian National University in Canberra. Later, he worked in Laser Zentrum Hannover e.V. in Germany between 2009-2011 as a scientific employee then from 2011 to 2017 as head of the research group Nanomaterials. Additionally, between 2011-2017 he headed the research unit Nanoparticles in the German cluster of excellence REBIRTH - From Regenerative Medicine to Reconstructive Therapy in the Hannover Medical School. Between 2015-2017 he was responsible of the research module “Laser-based methods - switchable implant coatings with drug-releasing nanoparticles” within the interdisciplinary research cluster Biofabrication for NIFE in Germany. At present, he is head of the research group Advanced Implant Solutions at the Austrian Institute of Technology.

Development of laser-based multifunctional nanomaterials and nanocomposites, bioactive biodegradable and non-degradable implant materials and coatings, complex nanoparticles for local drug-release systems and the synthesis of ultrapure nanoparticles and nanoconjugates.

Professor Dehghani is a full time employee in the school of Chemical and Biomolecular Engineering at the University of Sydney. She is the director of ARC Food Processing Training Centre, the Director of Centre of Advanced Food Enginomics, an Associate member of IChemE and a member of ARC College of expert. She has been selected by Engineers Australia as one of the top 50 Engineers for innovation in research in 2016. She has been instrumental in building an interdisciplinary research environment that stimulates the interface and intersect of engineering, science, medicine, pharmacy, and agriculture. As a result of her achievement she has received the 2017 Award of Excellence in Chemical Engineering from Australia New Zealand Federation of Chemical Engineering. Her research team in collaboration with industry partners have worked together to provide pragmatic, cost-effective and environmentally sustainable solutions to a diverse range of issues, with the aim of improving lives

Her research is highly regarded, not only in academia but by industry. She has established long-term collaborations with the food and biotech private sectors and acquired substantive funding from national and international competitive grant applications. She is an inventor on 16 patents, including nine with potential end users. She has mentored more than 45 postgraduates and more than 100 honours and master researchers. She mentors several successful entrepreneurs. As a result the outcomes of her research led to establishment of a start-up Company, Trimph Pty Ltd, in 2015 by receiving over than $2 M fund from a private investor and government. This product has recently received approval from TGA for the clinical application.

Jacques DESBRIÈRES is Professor at University of Pau and Pays Adour (UPPA), Engineer from ENSC Paris and Doctor-Engineer from Grenoble University. After a position as the research engineer with Dowell Schlumberger related to the application of polymers in oil well operations, he joined Grenoble University in 1990 and then UPPA in 2004. He authored around 200 publications and 10 patents.

His research domain is concentrated on chemical modification of natural polymers and relations between their chemical structure, functional properties, and their applications. In the last years his research activities were dedicated to physico-chemistry (interfacial properties) of amphiphilic polysaccharide solutions and polysaccharide-surfactant interactions, hydrogels and particularly their characterization and their specific applications (biomedical or cosmetics applications, wastewater treatments) and new “green processes” applied to bio-sourced materials (microwave irradiation as an example). He is the member of Editorial board of Carbohydrate Polymers, Cellulose Chemistry and Technology and has teaching activities in physico-chemistry and polymer science. Finally, he is Doctor Honoris Causa of Technical University “Gheorghe Asachi” in Iasi (Romania) for his outstanding input in Polysaccharide science.

Dr Joaquin Rams is full professor of the Rey Juan Carlos University, currently being the Head of the Department of Applied Mathematics, Materials Science and Engineering and Electronics Technology. Before he has conducted research at the Complutense University of Madrid and at the Autonoma University of Madrid. He has made several research stays at the Stanford University and the University of Sussex in Brighton. He has also collaborated with other universities such as Sheffield University (UK), Queensland University (Au) and KIT (Ge), among others. He is evaluator of European Projects, as well as from other countries, and he is also Assessor of the Australian Research Council. He has been also Coordinator of the Materials Technology in the Spanish Evaluation and Prospective Agency

He has published a hundred papers in JRC journals and many invited lectures. He is PI of the Materials Science and Engineering Group at his university which has an active role in national and international projects. In the last years he has focused on the use of Magnesium alloys as biomaterials and in its modification for the optimization of its behavior.

Prof Ivan Chodák (PhD, DSc) is a senior scientist at Polymer Institute SAS in Bratislava. His scientific interests cover crosslinking of polyolefins (patented extremely efficient system for polypropylene crosslinking), multiphase systems, i.e. polymer blends and composites with polymeric matrices including nanocomposites. Investigation of biodegradable polymers belong to his most successful topics (patented material based on PHB and PLA with very high toughness, the production is under preparation). He is the author of over 150 scientific publications, 15 patents (4 of them applied in industry) HI = 24 (according to Scopus). Frequent and long-term cooperation with industry (DSM, BASF, Biomer, National Power, GE Plastics etc.)

Crosslinking of polyolefins (patented extremely efficient system for polypropylene crosslinking), multiphase systems, i.e. polymer blends and composites with polymeric matrices including nanocomposites. Investigation of biodegradable polymers belong to his most successful topics (patented material based on PHB and PLA with very high toughness, the production is under preparation).

Prof Yu-Long Yin was born on 23/01/1956 in Hunan, China. Prof. Yin attended Hunan Normal University, Changsha, China, where he obtained a Bachelor degree in Biology in 1978. He attended Huazhong Agricultural University, Wuhan, China from 1979 to 1982 and Queens University of Belfast, Belfast, UK from 1994 to 1997, from which he obtained his Masters and Doctorate degrees in Animal Nutrition, respectively. Prof. Yin is married to Ms. Lihua Tao and they have a son. Prof. Yin began his academic career as an assistant professor at Institute of Subtropical Agriculture, Changsha in 1986 and rose to the rank of professor in 1994. During this period, Prof. Yin was privileged to work with top scientists in advanced laboratories in the US, Germany and Canada, where he researched extensively into the subject of ideal digestibility and made notable contribution to knowledge on the subject of development and standardization of ideal digestibility in pigs. Back home in China, Prof. Yin has researched extensively and characterized virtually all the common Chinese feed ingredients used for pig feeding for their nutritive value and ileal digestibility contents. This has led to the development of up-to-date feed database used extensively in the Chinese feed industry. Apart from enhancing growth rate and profit margin in the pork industry, the development of the ileal digestibility methods and the use of ileal digestible values in feed formulation has the added advantage of reducing nitrogen and phosphorus emission to the environment, when used for feed formulation. Prof. Yin has won many international and national awards amongst which are the prestigious German Max-planck Gesellschaft Scholarship, 1985 and 1995, National Science and Technology Progress Prize of China in 1996, 1997 and 2008 amongst others. He has published a total of 364 scientific papers (131 papers in English and in Chinese), which have greatly advanced the field of animal nutrition worldwide.

Animal Production, Animal Feed, Nutrition and Physiology of Amino Acids and Protein, Gene Expression and Gene Therapy. Comparative Animal Nutrition; Growth and Development of Animals, Biology and Pathobiology of Nitric Oxide and Polyamines, Diabetes, Obesity and Cardiovascular Complications, Fetal Nutrition and Metabolism, Animal Models of Human Diseases, Nutritional Biochemistry and Physiology.

Anand Ramamurthi is an Associate Professor of Molecular Medicine and Biomedical Engineering at the Cleveland Clinic with adjunct appointments at the University of Akron (Integrated Biosciences Program), and Case Western Reserve University (BME). He received his PhD in Chemical Engineering, from Oklahoma State University, Stillwater, OK in 1999 and subsequently was an American Heart Association postdoctoral fellow at the Lerner Research Institute of the Cleveland Clinic (1999-2001), where he developed novel, glycosaminoglycan (GAG)-based biomaterials for biomimetic tissue engineering of aortic heart valve replacements. Prior to his appointment at the Cleveland Clinic in 2010, Dr. Ramamurthi was a tenured faculty in the Departments of Bioengineering at Clemson University and Regenerative Medicine and Cell Biology the Medical University of South Carolina, Charleston, SC. His research program focuses on enabling biomimetic regeneration and repair of extracellular matrix structures, specifically the poorly regenerated elastic matrix component, both in vitro, and in situ at sites of chronic matrix disruption (e.g., abdominal aortic aneurysms and pelvic organ prolapse). His research projects span cardiovascular tissue engineering, biomimetic vascular matrix assembly, GAG-based biomaterials for vascular endothelialization and matrix regenerative repair, mechanisms of matrix degeneration in abdominal aortic aneurysms (AAAs), directed matrix regenerative therapies for AAAs, vascular nanomedicine, stem cell -based matrix regenerative therapies, in vivo bioreactor systems for vascular tissue engineering. He is a member of several international professional societies in the cardiovascular sciences, biomaterials, and tissue engineering fields, and is a Professional Member of the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology. He serves on several national committees such as that of the North American Vascular Biology Organization (NAVBO), on the editorial broad of several scientific journals in the field of Tissue Engineering, Regenerative Medicine, and Vascular Biomedicine, and actively reviews for the NIH, NSF, AHA, and nearly 30 journals including Tissue Engineering, Biomaterials, and Acta Biomaterialia. He serves on the external advisory board of the NIH-supported Center for Biomedical Research Excellence (COBRE) in Biomaterials for Tissue Regeneration (CBTR) in South Carolina, and on the Inventions Peer Review Committee of Cleveland Clinic Innovations, the commercialization wing of the Cleveland Clinic. Anand has been an invited presenter at several national conferences and has chaired past conference symposia on the topic of directed elastic matrix regenerative repair. He has 50 peer-reviewed publications to date, numerous abstracts, proceedings, several book chapters, and approved and filed patents. His research has been funded by the NIH, AHA national and affiliate centers, NSF, and industry.

Vascular Tissue Engineering, Cardiovascular degenerative Medicine, Biomimetic Matrix Assembly, Elastin Pathology and Elastic Matrix Regenerative Repair, Therapies for Aortic Aneurysms, Blood-Material Compatibility, Glycosaminoglycan-Based Biomaterials, Stem Cells for Vascular Therapies

Dr Abbas Amini is an associate lecturer, a registered member of Western Sydney University graduate supervisory board at the School of Computing, Engineering and Mathematics, and the member of Work Health and Safety Committee of the same university, Penrith Campus. Before joining the Western Sydney University, he conducted research with other Australian universities and CSIRO, as a postdoctoral research fellow at Monash University and Deakin University, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas started his teaching, industrial and scientific journey from obtaining an associate’s degree in mathematics, and BSc, MSc, and PhD (from the Hong Kong University of Science and Technology) in mechanical engineering and nanotechnology. Since then, he has updated himself with several Australian and Canadian nationally recognized professional certificates and diplomas, e.g., FULT (Foundations of University Learning and Teaching form Western Sydney University), TAE, WHS, CNC etc. With his intense schedule, he has been extensively involved in teaching for many years in different sectors (including Western Sydney University), and worked in industry, e.g., Magna Powertrain, Toronto, Canada, as an engineer and industrial designer. Dr Amini is a member of American Society of Mechanical Engineers (ASME), an editor of more than ten journals, and a committee member of 14 international conferences to-date. In academic supervisory assignments, Abbas is supervising four PhD and two MSc graduate students, at present.

indentation methods, shape memory alloys, water treatment, drug delivery systems, piezoelectric materials, biomedical materials, graphene, graphane, CNTs, biodegradable polymeric nano-composites, TiO2, ZnO, environmental sustainability and water efficiency, experimental analysis, multi-scale (nano to macro) modelling of multi-physics phenomena, phase transition, mechanics of materials, fabrication of modern composites, manufacturing, offshore naval structures, and ship design.

Ajay Kumar Mishra is a full Professor at the Nanotechnology and Water Sustainability Research Unit at College of Science, Engineering & Technology, University of South Africa, Florida Science Campus, South Africa. He received his B. Sc, M. Sc., degrees in 1997 and 2001 respectively from Purvanchal University Jaunpur, India and M. Phil. and Ph.D. degrees in 2003 and 2007, respectively, from The University of Delhi, India. From March 2006 to September 2009, he was postdoctoral fellows at various South African Institutes/Universities. In addition, he was appointed as “Senior Lecturer” in October 2009 at the Department of Applied Chemistry, University of Johannesburg, South Africa where he was promoted to “Associate Professor” in November 2011 until December 2014. Recently, he was appointed by University of South Africa as “Full Professor” since January 2015. He is also working as “Adjunct Professor” at Jiangsu University, China. His research interests include synthesis of multifunctional nano-materials, nano-composites, biopolymer and/or petrochemical based biodegradable polymers, polymers based materials/composites, smart materials, CNT and graphene based composite materials and water research. He has authored over 100 scientific papers. He has hosted several visiting researchers/scientists/postdocs in his group. He has also developed a number of collaborations worldwide. He has delivered a number of including Plenary/Keynote/Invited Lectures. For his outstanding research profile, he was awarded a number of international awards. Prof. Mishra also served as Associate Editor as well as member of the editorial board of many peer-reviewed international journals. He has edited several books by the renowned publishers and also reviewer of many international journals. He is serving as member advisory board of a number of international scientific societies, conferences and workshops.

synthesis of multifunctional nano-materials, nano-composites, biopolymer and/or petrochemical based biodegradable polymers, polymers based materials/composites, smart materials, CNT and graphene based composite materials and water research

Since Sept 1, 2014, Lars Montelius is Director General for INL, The International Iberian nanotechnology Laboratory located in Braga, Portugal. INL is the only by legal status International nanotechnology RTO worldwide. Lars Montelius is also Professor in Nanotechnology at Lund University, Sweden. During his 30 years of nanotechnology activities he has held several leading positions within academia, networks and EU-and professional societies. LM has published more than 144 articles, given more than 70 invited talks and has filed 24 patents. LM is also the founder of several nanotech companies. Currently he is the President for IUVSTA: The International Union for Vacuum Science, Technique and Applications comprising 34 national societies with more than 100 000 scientists, researchers and practitioners in the field and he is Working Group Chair of the two European Technology.

Nanomedicine, Environment monitoring, security and food quality control, Nanoelectronics, Nanomachines & Nanomanipulation

-MSc. José Manuel Baena, research associate "Advanced therapies: differentiation, regeneration and cancer" IBIMER,CIBM, Universidad de Granada Founder of BRECA Health Care, pioneer in 3D printed custom made implants for orthopedic surgery, and REGEMAT 3D, the first Spanish bioprinting company. Expert in innovation, business development and internationalization, lecturer in some business schools, he is passionate about biomedicine and technology. In his free time he is also researcher at the Biopathology and Regenerative Medicine Institute (IBIMER). -MSc. José Manuel Baena, Global biotech entrepreneur, research associate at the Advanced therapies: differentiation, regeneration and cancer group of the UGR. Holds a degree in Industrial Engineering from the Polytechnic University of Valencia (Spain) and a Postgraduate Degree in Mechanical Engineering from TU Braunschweig (Germany). Jose Manuel is working in biomedical engineering since 2008, after attending a postgraduate course on Biomechanical Engineering at the University of Buenos Aires (Argentina). He is also MSc in Motorsport Engineering from Oxford Brookes University, UK and a PhD candidate in Biomedicine (expected 2016). His career in R&D project management and Executive Management will provide the knowledge necessary for proper implementation and development. es.linkedin.com/in/jmbaena/

Stem cells based therapies and regenerative medicine. Scaffolds for tissue engineering. Differentiation, dedifferentiation and transdifferentiation of stem cells. Invitro tumoral models.Implants.

Graduated with honors and received PhD in Physics from Moscow Institute of Physics and Technology. Started his scientific carrier at P.N. Lebedev Institute of Russian Academy of Sciences in Moscow and later worked in many research centers worldwide. At present, he is Professor of Physics at Leibniz University Hannover and Head of Nanotechnology Department at the Laser Zentrum Hannover e.V.

Laser physics and laser applications, quantum and nonlinear optics, nano- and biophotonics, nanoengineering, biomedical implants and devices, tissue engineering and regenerative medicine

Dr. Bharat Bhushan received an M.S. in mechanical engineering from the Massachusetts Institute of Technology in 1971, an M.S. in mechanics and a Ph.D. in mechanical engineering from the University of Colorado at Boulder in 1973 and 1976, respectively, an MBA from Rensselaer Polytechnic Institute at Troy, NY in 1980, Doctor Technicae from the University of Trondheim at Trondheim, Norway in 1990, a Doctor of Technical Sciences from the Warsaw University of Technology at Warsaw, Poland in 1996, and Doctor Honouris Causa from the National Academy of Sciences at Gomel, Belarus in 2000 and University of Kragujevac, Serbia in 2011. He is a registered professional engineer. He is presently an Ohio Eminent Scholar and The Howard D. Winbigler Professor in the College of Engineering, and the Director of the Nanoprobe Laboratory for Bio- & Nanotechnology and Biomimetics (NLB2) and affiliated faculty in John Glenn College of Public Affairs at the Ohio State University, Columbus, Ohio. In 2013-14, he served as an ASME/AAAS Science & Technology Policy Fellow, House Committee on Science, Space & Technology, United States Congress, Washington, DC. His research interests include fundamental studies with a focus on scanning probe techniques in the interdisciplinary areas of bio/nanotribology, bio/nanomechanics and bio/nanomaterials characterization and applications to bio/nanotechnology, and biomimetics. He is an internationally recognized expert of bio/nanotribology and bio/nanomechanics using scanning probe microscopy, and is one of the most prolific authors. He is considered by some a pioneer of the tribology and mechanics of magnetic storage devices. He has authored 8 scientific books, 90+ handbook chapters, 800+ scientific papers (h-index – 76+; ISI Highly Cited Researcher in Materials Science since 2007 and in Biology and Biochemistry since 2013; ISI Top 5% Cited Authors for Journals in Chemistry since 2011), and 60+ technical reports. He has also edited 50+ books and holds 20 U.S. and foreign patents. He is co-editor of Springer NanoScience and Technology Series and co-editor of Microsystem Technologies, and Member of Editorial Board of PNAS. He has given more than 400 invited presentations on six continents and more than 200 keynote/plenary addresses at major international conferences.

Bionanotribology, Bionanomechanics and Bionanomaterials

Dr Joaquin Rams is full professor of the Rey Juan Carlos University, currently being the Head of the Department of Applied Mathematics, Materials Science and Engineering and Electronics Technolgy. Before he has conducted research at the Complutense University of Madrid and he obtained his PhD at the Autonoma University of Madrid. He has made several research stays at the Stanford University and the University of Sussex in Brighton. He has also collaborated with other universities such as Sheffield University (UK), Queensland University (Au) and KIT (Ge), among others. He is evaluator of European Projects, as well as from other countries, and he is also Assessor of the Australian Research Council. He has been also Coordinator of the Materials Technology in the Spanish Evaluation and Prospective Agency. He has published a hundred papers in JRC journals and many invited lectures. He is PI of the Materials Science and Engineering Group at his university which has an active role in national and international projects. In the last years he has focused on the use of Magnesium alloys as biomaterials and in its modification for the optimization of its behavior.

Biomaterials, Applied Mathematics, Materials Science and Engineering and Electronics Technolgy

Lorenzo Pastrana is Professor of Food Science at UVIGO where he was the Director of the Centre of Research transference and Innovation (CITI) and Head of Knowledge Transfer Office (2009-2010). He founded the Galician Agri-Food Technology Platform (2006) join academic institutions and companies paving the clustering of the sector. Since 2015 he is Head of the Department of Life Sciences at INL that include three Research Units, namely Food, Environment and Health. At INL his research, leading the Food Processing Group, is marked oriented with a multidisciplinary approach integrating methods and concepts of the biotechnology, nanotechnology and mathematical modelling. Currently he is working in three main research lines: Food Structure with emphasis in 3D printing materials, encapsulation technologies for improving functional foods and active and intelligent food packaging. He is author of more than 120 scientific contributions and 4 licenced patents relating the development of new food products and process. He was the PI of more than 30 National and European research projects and contracts arising funds around 2000K€.

Food Structure with emphasis in 3D printing materials, encapsulation technologies for improving functional foods and active and intelligent food packaging.

Dr. Fenniri received all his degrees from the Université de Strasbourg, France. After a postdoctoral fellowship at the Scripps Research Institute, CA, USA, he moved to Purdue University, IN, USA, where he initiated his independent academic career, and established the Purdue Laboratory for Chemical Nanotechnology (1999). In 2003, He joined the National Research Council as a founding member of the National Institute for Nanotechnology and as professor of chemistry and bioengineering at the University of Alberta (Canada, 2003-2013). Dr. Fenniri is currently Professor of Chemical Engineering and Bioengineering at Northeastern University, Boston, MA, USA. Dr. Fenniri’s contributions appeared in over 220 publications, 20 patents and patent applications, and over 500 contributed national and international conference papers. Dr. Fenniri has also lectured extensively around the globe and has been an invited professor at several institutes and universities.

Nanotechnology for biomedical applications, nanoscale materials for drug delivery, and cell therapeutics and regenerative medicine.

Yongmei Zheng, PhD, is a professor at School of Chemistry, Beihang University. Research interests are focused on bioinspired surfaces with gradient micro- and nanostructures to control dynamic wettability, which develop the surfaces with characteristics of water repellency, anti-icing, anti-frosting, or tiny droplet transport, fog-harvesting and so on. Publications are more than 90 SCI papers included in Nature, Adv. Mater., Angew. Chem. Int. Ed., ACS Nano, Chem. Mater., J. Mater. Chem. A, etc., with 12 Cover stories, and a book “bioinspired wettability surfaces: Development in micro- and nanostructures” by Pan Standard Publishing, USA. Her work was highlight as scientist on News of Royal Society of Chemistry, ChemistryWorld in 2014. She is a senior member of Chinese Composite Materials Society (CSCM), member of Chinese Chemistry Society (CCS), American Chemistry Society (ACS), Fellow member of NANOSMAT Society, International Society of Bionic Engineering (ISBE), and International Association of Advanced Materials (IAAM), Editorial board member of Scientific Report in nature. She won an ISBE outstanding contribution award in 2016 by ISBE, in Ningbo of China, and also an IAAM award Medal in 2016 by IAAM, in Sweden, due to the notable and outstanding contribution in field of "Advanced Materials Science and Technology".

Bioinspired wettability, bioinspired micro-/nanostructure, gradient wettable surface, water repellency, droplet driving/transport, fog-harvesting, etc.

Prof. Ch. Sanjay had joined GITAM University, Hyderabad as a Founder Campus Director in June 2009 till July 2014. At present, he is Dean and Principal, School of Technology, GITAM University and has been a member of Board of Management and Academic Council since 2009. He is a certified Corporate Director of World Council for Corporate Governance, UK and visited most of the South Asian Countries for Research and presenting papers in various International Conferences. He has more than 24 years of experience in Industry, Research & Teaching and had worked four years as a Associate Professor of Manufacturing Engineering and Management at Government Universities in Malaysia and Singapore. He was a key note speaker for more than 40 international and national conferences and a member of advisory and technical committee for more than 60 international conferences and had successfully organized 65 international and national conferences / workshops. He is member, Editorial Board and Reviewer for more than 20 international journals and evaluated 16 doctorial theses in mechanical / manufacturing / management / information technology of various universities and he is currently guiding 5 research scholars for their doctoral work. He has to his credit 4 books published by reputed publishers and authored more than 60 research papers and published in peer reviewed and indexed journals and conference proceedings. He is a Member of Academic council / Board of Studies / Research & Development Cell / Recruitment and Selection/purchasing/curriculum Design/ university inspections for various International / State / Deemed Universities since 2001.He is in recipient of many International and National award such as Academic Excellence, Research Excellence , Best Engineer, Best Principal award, Best Academic Administrator, Education leadership and Engineers Educator award.

IT applications in Manufacturing Engineering, Machine Tools & Cutting Tools, Materials Engineering, Artificial Intelligent Systems, Smart Materials & Composites, Industrial Engineering & Management, Product Design & Development, CAD/CAM/CIM, Robotics & Automation, Non-conventional Energy & Energy Management and Human Resource Management.

Dr. Laszlo SAJTI, graduated as a physicist in 2004 from the University of Szeged in Hungary, received PhD in 2007 in material sciences from the University of the Mediterranean Aix-Marseille in France, post-doctoral fellow between 2008-2009 with the excellence initiative of the Australian Federal Government in the Australian National University in Canberra. Later, he worked in Laser Zentrum Hannover e.V. in Germany between 2009-2011 as a scientific employee then from 2011 to 2017 as head of the research group Nanomaterials. Additionally, between 2011-2017 he headed the research unit Nanoparticles in the German cluster of excellence REBIRTH - From Regenerative Medicine to Reconstructive Therapy in the Hannover Medical School. Between 2015-2017 he was responsible of the research module “Laser-based methods - switchable implant coatings with drug-releasing nanoparticles” within the interdisciplinary research cluster Biofabrication for NIFE in Germany. At present, he is head of the research group Advanced Implant Solutions at the Austrian Institute of Technology.

Development of laser-based multifunctional nanomaterials and nanocomposites, bioactive biodegradable and non-degradable implant materials and coatings, complex nanoparticles for local drug-release systems and the synthesis of ultrapure nanoparticles and nanoconjugates.

Dr. Murugan Ramalingam is Professor at the Centre for Stem Cell Research (a unit of the Institute for Stem Cell Biology and Regenerative Medicine-Bengaluru), Christian Medical College Campus, India. Concurrently he is Adjunct Professor at the Tohoku University, Japan. Prior to joining the CSCR, he was Associate Professor of Biomaterials and Tissue Engineering at the Institut National de la Santé et de la Recherche Médicale, Faculté de Chirurgie Dentaire, Université de Strasbourg, France. He has worked at the WPI Advanced Institute for Materials Research, Japan, as an Assistant Professor. He has also worked at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH), under the U.S. National Academies Associateship program. He received his Ph.D. in Biomaterials from the University of Madras. He has also undergone training in Ethical and Policy issues on Stem Cells from Harvard University, USA, and in Operations Management from the University of Illinois-Chicago. His current research interests are focused on the development of multiphase biomedical materials, through conventional to nanotechnology to biomimetic approaches, microfabrication, cell patterning, stem cell differentiation, tissue engineering and drug delivery. He is the author of ~300 publications, including peer-reviewed journal papers, conference proceedings, book chapters, authored books, edited books, and patents relevant to biomaterials, stem cells, and tissue engineering. His current h-index is 30 with ~7300 citations. He has organized several international conferences and chaired Biomaterials, Nanobiotechnology, Stem Cells and Tissue Engineering sessions. He also serves as a board member of several international scientific and research committees in various public and private bodies and grant reviewer of various international funding agencies. He serves on the editorial boards of multiple biomaterials and tissue engineering-related journals, including the Editor-in-Chief of the Journal of Biomaterials and Tissue Engineering and the Journal of Bionanoscience. He is a recipient of several prestigious fellowships and awards, including CSIR Fellowship (India), SMF Fellowship (Singapore), NRC National Academies Fellowship (USA), Nationale Professeur des Universités (France), Fellow of Institute of Nanotechnology (UK) and Fellow of Royal Society of Chemistry (UK).

His current research interests are focused on the development of multiphase biomedical materials, through conventional to nanotechnology to biomimetic approaches, microfabrication, cell patterning, stem cell differentiation, tissue engineering and drug delivery.

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine and Director of Nanotechnology and Regenerative Medicine Company has worked at Royal Free Hospital and University College London over 25 years, published over 647 peer-reviewed research papers, edited 2 books and contributed to 39 book chapter, and 14 UK and International patents. He is currently director of NanoRegMed Ltd, working in commercialisation of his research. During his career he has led and managed many large projects with multidisciplinary teams with very successful outcomes in terms of commercialisation and translation to patients including 1) The development and commercialisation of a bypass graft for vascular access for haemodialysis; 2) The development of bioreactors with fluid dynamic systems; 3) Non-invasive techniques to monitor viscoelastic properties of cardiovascular system and many others. He was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade & Investment (UKTI) in the Life Sciences and Healthcare category. European Life Science Awards. Winner of most innovative new product 2012 “Synthetic Trachea”. Hamburg, Germany, 29 may 2012. He also was awarded Nanosmat Prize in August 2013 in Spain for his achievements and contributions to Nanoscience and nanotechnology. In 2016 in Brussels he received the Heals distinguish research award in recognition for his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. He developed world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials and bioactive molecules and stem cells technology. He has created a huge amount of media interest for his translational research work to first in man, including; world first synthetic trachea, bypass graft, lacrimal duct, and other surgical implants.

Development of Nanomaterial,cardiovascular implant,nanofluorescence particle including quantum dots for localisation and treatment of cancer,Stem cells for development of organ using tissue engineering. Development of organ using biodegradation nanomaterials and stem cells, including liver, intestine,Hepatic microcirculation and oxygenation using optical technique,Ischemia reperfusion injury and preconditioning.

Professor at Dental Basic Science, College dentistry, Mosul University, Iraq. Have PhD degree in Dental chemistry. He has published more 100 researches papers in national and international academic journals and authored 22 books. His research interests include dental chemistry, medical chemistry, and inorganic chemistry. He is editorial member in more than 140 international journals. He Nominated as a member of the organizing committees for a number of international and local conferences.

Dental chemistry, Medical chemistry, and inorganic chemistry

Dr. O.L. Shanmugasundaram is working as Professor in the Department of Textile Technology at K.S.Rangasamy College of Technology, India. He received his Diploma in Textile Processing in the year 1996 from Erode Institute of Technology, India. He obtained his B.Tech. degree in Textile Technology in 2000 from Bannari Amman Institute of Technology, India. He has qualified in the GATE Examination with 83.21 percentile score in the year 2003. He received his M.Tech. degree in Textile Technology in the year 2005 from Alagappa College of Technology, Anna University, Chennai and Ph.D. in Medical Textiles from Anna University in the year 2011. He published 26 research papers in peer reviewed Journals with impact factor. He has to his credit 20 papers presented in International Conferences and 5 others in National Conferences. His areas of interest are Application of Nanotechnology in Textiles, Medical Textiles, Textile Chemical Processing Technical Textiles and Fibre Science & Technology. He had 14 years of teaching, research and admin experience in an engineering college. He is acting as an editorial board member and reviewer in many refereed journals including Elsevier and Springer Journals and also organizing committee member and scientific committee member in many International and National Conferences in India and abroad.

Healthcare and Hygiene Textiles, synthesis of nanoparticles/polymers and its applications in wound dressings, development of drug releasing sutures.

Dr. Fenniri was educated at the Université de Strasbourg, France, receiving his undergraduate degree in chemistry and biochemistry, and his M.Sc./Ph.D. degrees in supramolecular science and engineering under Nobel Laureate Professor Jean-Marie Lehn. He then joined the Scripps Research Institute in California, USA, where he carried out his postdoctoral training under the supervision of Professor Richard A. Lerner. In 1997 he moved to Purdue University, where he initiated his independent academic career, and established the Purdue Laboratory for Chemical Nanotechnology. In 2003, He joined National Institute for Nanotechnology (NINT) as a founding member and the University of Alberta where he led the Supramolecular Nanoscale Assembly program. Since 2013, Dr. Fenniri has been Professor of Chemical and Biomedical Engineering at Northeastern University, Boston, MA, USA. Dr. Fenniri has achieved international recognition as a leader in the areas of self-assembly, supramolecular chemistry, nanomedicine, and materials sciences. His group works at the forefront of basic and applied nanosciences, in collaboration with various academic institutions, federal laboratories, and with the private sector. Dr. Fenniri’s contributions appeared in over 220 publications, 20 patents and patent applications, and over 450 contributed national and international conference papers. Dr. Fenniri has also presented his work in over 170 invited distinguished lectures, colloquia and seminars around the globe. Dr. Fenniri is the recipient of several academic and professional honours and awards, including the Xerox UAC Award, the 3M Faculty Award, the Showalter Trust Fund Award, the Trask Trust Fund Technology Innovation Award, the Cottrell Teacher Scholar Award, and the US National Science Foundation Career Award. Dr. Fenniri is Member of the Editorial Board of several scientific journals and serves on several national and international scientific boards, panels, and committees.

Nanotechnology for biomedical applications, nanoscale materials for drug delivery, and cell therapeutics and regenerative medicine.

Esmaiel Jabbari completed his PhD at Purdue University and postdoctoral studies at Monsanto, Rice University, and Mayo Clinic. He is Full Professor of Chemical and Biomedical Engineering and Director of Biomimetic Materials and Tissue Engineering Laboratory at University of South Carolina. He is internationally known for his work on synthesis and processing of cell-responsive polymers and hydrogels for applications in tissue engineering and regenerative medicine. He received the Berton Rahn Award from the AO Foundation in 2012 and the Stephen Milam Award from the Oral and Maxillofacial Surgery Foundation in 2008. He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2013. He has published >230 books, book chapters, peer-reviewed journal articles, and conference proceedings, and presented >260 seminars at national and international conferences on biomaterials, tissue engineering, and drug delivery. He has mentored >130 visiting scholars, post-doctoral researchers, doctoral students, and undergraduate students. He is a member of numerous scientific organizations including BMES, SFB, TERMIS, MRS, EMBS, ACS, AIChE, and AACR.

Bioinspired materials, Skeletal tissue engineering, Multi‐scale composite materials, Self-assembled nanogels for growth factor delivery, Drug targeting to cancer stem cells, Stem cell encapsulation and delivery, Model gels to control cell microenvironment

Julie Allickson, Director of the Regenerative Medicine Clinical Center at Wake Forest Institute for Regenerative Medicine focuses on the translation of regenerative medicine products including cell therapy, tissue engineering, biomaterials and devices. This process begins at Proof-of-Concept where early discussion with regulators and clinicians are critical in moving the technology from the bench to the bedside. The Translational Team includes Quality Assurance, Quality Control, Regulatory Affairs, Process Development and the GMP-complaint Manufacturing Facility. Prior to joining the institute, she was an Executive Officer of the company and Vice President of Laboratory Operations and R & D at Cryo-Cell International, Inc. As Vice President of the Laboratory Dr. Allickson was responsible for all technical aspects of Laboratory Operations along with Research and Development activities associated with adult stem cells, and the commercialization of a unique stem cell harvested from menstrual blood. Prior to this position, Dr. Allickson worked for the University Of Miami School Of Medicine, Diabetes Research Institute as the Laboratory Director of the cGMP Hematopoietic Cell Processing Facility. She was responsible for the design and implementation of the State Licensed Clinical Flow Cytometry Laboratory. Dr. Allickson was the lead in Regulatory Affairs for the processing laboratory of Islet and Hematopoietic Cell products which included oversight of all Investigational New Drugs (IND) and external regulations. Prior to working for the University of Miami she worked for the American Red Cross managing the Hematopoietic Cell Processing and Platelet Serology Laboratory. During her tenure at the American Red Cross she served as a member of the National Stem Cell Task Force and participated in the preparation of national protocols developed for Hematopoietic Cell Processing Laboratories. Dr. Allickson was part of the team to perform the very first Bone Marrow Transplant at the University of Miami in 1990. Dr. Allickson has 25 years of experience in Cellular Therapy, Cellular Processing and Regenerative Medicine. She has a Doctorate in Health Sciences along with a Master’s Degree in Medical Laboratory Sciences. She is one of the founding members of the International Society of Cellular Therapy in 1992, has been a member of the American Association of Blood Banks (AABB) for 25 years along with other organizations such as TERMIS. She has presented at meetings related to cellular therapy, tissue engineering and biomaterial clinical translation. Dr. Allickson is on the AABB Standards Committee for Cell Therapy Product Services , Technical Advisory Board for Tissue Engineered Products under ICCBBA, Cord Blood Association on Market Expansion and Vice Chair of the Quality Committee and the ISCT Commercialization Committee.

Cellular Therapy, Cellular Processing and Regenerative Medicine,tissue engineering and biomaterial clinical translation.

Dr. Murugan Ramalingam is Professor at the Centre for Stem Cell Research (a unit of the Institute for Stem Cell Biology and Regenerative Medicine-Bengaluru), Christian Medical College Campus, India. Concurrently he is Adjunct Professor at the Tohoku University, Japan. Prior to joining the CSCR, he was Associate Professor of Biomaterials and Tissue Engineering at the Institut National de la Santé et de la Recherche Médicale, Faculté de Chirurgie Dentaire, Université de Strasbourg, France. He has worked at the WPI Advanced Institute for Materials Research, Japan, as an Assistant Professor. He has also worked at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH), under the U.S. National Academies Associateship program. He received his Ph.D. in Biomaterials from the University of Madras. He has also undergone training in Ethical and Policy issues on Stem Cells from Harvard University, USA, and in Operations Management from the University of Illinois-Chicago. His current research interests are focused on the development of multiphase biomedical materials, through conventional to nanotechnology to biomimetic approaches, microfabrication, cell patterning, stem cell differentiation, tissue engineering and drug delivery. He is the author of over 250 publications, including peer-reviewed journal papers, conference proceedings, book chapters, authored books, edited books, and patents relevant to biomaterials, stem cells, and tissue engineering. His current h-index is 27 with over 5200 citations. He has organized several international conferences and chaired Biomaterials, Nanobiotechnology, Stem Cells and Tissue Engineering sessions. He also serves as a board member of several international scientific and research committees in various public and private bodies and grant reviewer of various international funding agencies. He serves on the editorial boards of multiple biomaterials and tissue engineering-related journals, including as the Editor-in-Chief of the Journal of Biomaterials and Tissue Engineering, the Journal of Bionanoscience and the American Journal of Stem Cell Research. He is a recipient of several prestigious fellowships and awards, including CSIR Fellowship (India), SMF Fellowship (Singapore), NRC National Academies Fellowship (USA), Nationale Professeur des Universités (France), Fellow of Institute of Nanotechnology (UK) and Fellow of Royal Society of Chemistry (UK).

His current research interests are focused on the development of multiphase biomedical materials, through conventional to nanotechnology to biomimetic approaches, microfabrication, cell patterning, stem cell differentiation, tissue engineering and drug delivery.

Ajay Kumar Mishra is a full Professor at the Nanotechnology and Water Sustainability Research Unit at College of Science, Engineering & Technology, University of South Africa, Florida Science Campus, South Africa. He received his B. Sc, M. Sc., degrees in 1997 and 2001 respectively from Purvanchal University Jaunpur, India and M. Phil. and Ph.D. degrees in 2003 and 2007, respectively, from The University of Delhi, India. From March 2006 to September 2009, he was postdoctoral fellows at various South African Institutes/Universities. In addition, he was appointed as “Senior Lecturer” in October 2009 at the Department of Applied Chemistry, University of Johannesburg, South Africa where he was promoted to “Associate Professor” in November 2011 until December 2014. Recently, he was appointed by University of South Africa as “Full Professor” since January 2015. He is also working as “Adjunct Professor” at Jiangsu University, China. His research interests include synthesis of multifunctional nano-materials, nano-composites, biopolymer and/or petrochemical based biodegradable polymers, polymers based materials/composites, smart materials, CNT and graphene based composite materials and water research. He has authored over 100 scientific papers. He has hosted several visiting researchers/scientists/postdocs in his group. He has also developed a number of collaborations worldwide. He has delivered a number of including Plenary/Keynote/Invited Lectures. For his outstanding research profile, he was awarded a number of international awards. Prof. Mishra also served as Associate Editor as well as member of the editorial board of many peer-reviewed international journals. He has edited several books by the renowned publishers and also reviewer of many international journals. He is serving as member advisory board of a number of international scientific societies, conferences and workshops.

synthesis of multifunctional nano-materials, nano-composites, biopolymer and/or petrochemical based biodegradable polymers, polymers based materials/composites, smart materials, CNT and graphene based composite materials and water research

-MSc. José Manuel Baena, research associate "Advanced therapies: differentiation, regeneration and cancer" IBIMER,CIBM, Universidad de Granada Founder of BRECA Health Care, pioneer in 3D printed custom made implants for orthopedic surgery, and REGEMAT 3D, the first Spanish bioprinting company. Expert in innovation, business development and internationalization, lecturer in some business schools, he is passionate about biomedicine and technology. In his free time he is also researcher at the Biopathology and Regenerative Medicine Institute (IBIMER). -MSc. José Manuel Baena, Global biotech entrepreneur, research associate at the Advanced therapies: differentiation, regeneration and cancer group of the UGR. Holds a degree in Industrial Engineering from the Polytechnic University of Valencia (Spain) and a Postgraduate Degree in Mechanical Engineering from TU Braunschweig (Germany). Jose Manuel is working in biomedical engineering since 2008, after attending a postgraduate course on Biomechanical Engineering at the University of Buenos Aires (Argentina). He is also MSc in Motorsport Engineering from Oxford Brookes University, UK and a PhD candidate in Biomedicine (expected 2016). His career in R&D project management and Executive Management will provide the knowledge necessary for proper implementation and development. es.linkedin.com/in/jmbaena/

Stem cells based therapies and regenerative medicine. Scaffolds for tissue engineering. Differentiation, dedifferentiation and transdifferentiation of stem cells. Invitro tumoral models.Implants.

Professor Ramesh K. Agarwal is the William Palm Professor of Engineering and the director of Aerospace Engineering Program and Aerospace Research and Education Center at Washington University in St. Louis from 1994 to 200. He was the Sam Bloomfield Distinguished Professor and Executive Director of the National Institute for Aviation Research at Wichita State University. Dr. Agarwal received Ph.D in Aeronautical Sciences from Stanford University in 1975, M.S. in Aeronautical Engineering from the University of Minnesota in 1969 and B.S. in Mechanical Engineering from Indian Institute of Technology, Kharagpur, India in 1968. Professor Agarwal has worked in Computational Fluid Dynamics (CFD), renewable energy systems and nanotechnology. He is the author and coauthor of over 300 publications and serves on the editorial board of fifteen journals. Dr. Agarwal is a Fellow of fifteen societies including American Association for Advancement of Science (AAAS), American Institute of Aeronautics and Astronautics (AIAA), American Physical Society (APS), American Society of Mechanical Engineers, Society of Manufacturing Engineers (SME), Institute of Electrical and Electronics Engineers (IEEE), American Academy of Mechanics (AAM), and Institute of Physics. Astronautics (AIAA), American Physical Society

Nanomaterials, Carbon Nanostructures, Nanoparticles, Numerical Modeling and Simulation

Dr. Elisabeth Engel, associate professor since 2010, got her Ph.D in 2003, in bone metabolism diseases in medical School. She was awarded with a postdoc fellow from the Ministry of Science at the Technical University of Catalonia in Biomaterials for bone tissue regeneration and she is associate professor since 2010 at this University. She was appointed as PI at the Group of Biomaterials for Regenerative Therapies since the September of 2012 at the Institute for Bioengineering of Catalonia. Her research interests include the preparation and design of materials and scaffolds for in vitro and in vivo fundamental studies, and a further focus is the provision of useful tools to assess mechanisms that govern cell behavior in regenerative medicine. She has published more than 85 papers in JRC journals and many invited lectures and got an award for technological research (Barcelona City Award). Her group conducts several transference and translational projects with pharma and biomedical device industry and participates actively in European projects.

Her research interests include the preparation and design of materials and scaffolds for in vitro and in vivo fundamental studies, and a further focus is the provision of useful tools to assess mechanisms that govern cell behavior in regenerative medicine.

Since Sept 1, 2014, Lars Montelius is Director General for INL, The International Iberian nanotechnology Laboratory located in Braga, Portugal. INL is the only by legal status International nanotechnology RTO worldwide. Lars Montelius is also Professor in Nanotechnology at Lund University, Sweden. During his 30 years of nanotechnology activities he has held several leading positions within academia, networks and EU-and professional societies. LM has published more than 144 articles, given more than 70 invited talks and has filed 24 patents. LM is also the founder of several nanotech companies. Currently he is the President for IUVSTA: The International Union for Vacuum Science, Technique and Applications comprising 34 national societies with more than 100 000 scientists, researchers and practitioners in the field and he is Working Group Chair of the two European Technology.

Nanomedicine Environment monitoring, security and food quality control Nanoelectronics Nanomachines & Nanomanipulation

Prof. Xianfang Zhu is one of the earliest scientists who initialized nanoresearch in China in 1985 with over 30 years of research, teaching, and industrial experience in a wide range of materials (metal, ceramic, semiconductor, biomaterials, and polymer) science and engineering areas. He received PhD in Electronic Materials Engineering on nanostructures and their metastability in silicon induced by ion bombardment at the Australian National University in Canberra. Thereafter, he joined University of Illinois at Urbana-Champaign as a postdoctoral researcher, working on the stability of nanostructures in semiconductors under energetic beams irradiation at the Frederick Seitz Materials Research Laboratory to extend his concepts and explore nanoinstability under electron beam irradiation as well as to develop inorganic/organic coreshell nanostructure. He once also worked as associate professor at the Institute of Solid State Physics, Chinese Academy of Sciences; as a visiting scholar at National University of Singapore; as a senior researcher at the ODU Applied Research Centre in the Jefferson Lab; and as an assistant professor at the University of Georgia on fabrication of low dimensional nanostructures for potential nanotechnology and nanodevice applications. His current research interests are focused on structural instabilities of low dimensional nanostructures under external excitations, energetic beam nanoprocessing, controllable fabrication and growth of low dimensional nanostructures, controllable assembling and construction of large scale arrays of zero dimensional nanostructures, organic and inorganic hybrid at nanoscale, and functionalization of nanostructure etc. Prof. Zhu has (co-) authored over 100 publications, filed 8 patents, chaired; co-chaired, or served as committee or advisory board member at, over 30 international or national conferences, and presented over 70 invited lectures and talks at universities; research institutes; and major international conferences worldwide. He is editor-in-chief of Scientific Journal of Physical Science, associate editor of International Journal of Molecular Engineering and on editorial board of several journals such as Chin Sci Bull etc. He is also an active referee for over 10 top international journals such as Appl Phys Lett, J Phys Chem, Cryst Eng Comm, Carbon, Nanoscale, J Mater Chem, Nano Research, Scientific Reports, ACS Omega, and Chin Phys Lett etc. He is presently the Director of the China-Australia Joint Laboratory for Functional Nanomaterials, an adjunct professor at The University of Queensland in Australia, and a full-time professor in the Department of Physics at Xiamen University in China, as well as the chief scientist for the AMAC International Inc., USA.

His current research interests are focused on structural instabilities of low dimensional nanostructures under external excitations, energetic beam nanoprocessing, controllable fabrication and growth of low dimensional nanostructures, controllable assembling and construction of large scale arrays of zero dimensional nanostructures, organic and inorganic hybrid at nanoscale, and functionalization of nanostructure etc.

Dr. Nadia Benkirane is Research director and head of the “ Osteoarticular and Dental regenerative Nanomedicine” laboratory, at INSERM (French National Institute for Health and Medical Research), UMR 1109, Strasbourg, France. She was leader of “Active Biomaterials and Tissue Engineering” team INSERM 977. She received her Ph.D. from University Louis Pasteur, ULP, Strasbourg, France for the work on Development of pseudopeptides as synthetic vaccines. Dr. Jessel (Benkirane) then held a postdoctoral position in collaboration with the Institut Pasteur, Paris, France, working on Immunotherapy HIV, and another postdoctoral position on the application of modified peptides as vaccines against FMDV (Plum Island Animal Disease Center, ARS, USDA, Greenport, NY 11944-0848, USA). She joined the INSERM U595 in 2002 as a post-doc, and received the diploma to direct the research (HDR) in 2004. Dr. Jessel got the permanent position (CR1) in the INSERM 595 laboratory in 2004 and Research Director (DR2) position in the INSERM 977 and head of “active Biomaterials and Tissue Engineering team from 2009 until 2012). Currently Research Director (DR1) in the INSERM UMR 1109 (Osteoarticular and Dental Regenerative Nanomedicine" and heads the team. Dr. Jessel possesses expertise in diverse fields of molecular and cellular biology, immunochemistry, tissue engineering and biomedical engineering. In the last 10 years, she focused her research on the bio-functionalization of multilayered polyelectrolyte architectures with emphasis on the use of these architectures to induce specific cellular responses and gain control over cell proliferation and differentiation. Dr. Benkirane-Jessel have 138 publications (h index: 36) with peer-reviewed publications in high impact factor journals (Proc. Nat. Acad. Sci. USA; Adv. Mater.; Adv. Funct. Mater.; Small; Nanoletters, Biomaterials, ACS Nano), 5 chapters reviews and 5 international patents, she is a regular referee for a number of scientific journals (Nature nanotechnology, Nature Materials, ACS nano, Biomaterials, Nanoletters…). She is under the contract (Interface INSERM/Clinic 2008-2013) and she got also “Prime d’Excellence Scientifique” from the INSERM, 2010-2014 and the PEDR from the INSERM on 2016 for 4 years. Scientific topics: • Material Science • Nanomedicine • Regenerative Medicine • Tissue Engineering Keywords • Active living Biomaterials • Osteo-Articular Systems • Bone-tooth unit regeneration Most Relevant Publications 1. Briand J.-P, Benkirane-Jessel N et al., Bioactive coatings based on a polyelectrolyte multilayer architecture functionalized by embedded proteins. Proc Natl Acad Sci USA. 1997, 94:12545-12550 (IF-9.809). 2. Benkirane-Jessel N, et al., Bioactive coatings based on a polyelectrolyte multilayer architecture functionalized by embedded proteins. Adv. Mater. 2004, 15:692-695 (IF-15.409). 3. Benkirane-Jessel N et al., Control of monocyte morphology on and response to model surfaces for implants equipped with anti-inflammatory agents. Adv. Materials, 2004, 16, 1507-1511 (IF-15.409). 4. Benkirane-Jessel N et al., Pyridylamino-beta-cyclodextrin as a molecular chaperone for lipopolysaccharide embedded in a multilayered polyelectrolyte architecture. Adv. Materials, 2004, 14, 963-969 (IF-15.409). 5. Benkirane-Jessel N et al., Build-up of polypeptide multilayer coatings with anti-inflammatory properties based on the embedding of piroxicam-cyclodextrin complexes. Adv. Funct. Mater. 2004, 14:174-182 (IF-10.439). 6. Benkirane-Jessel N et al., Short-time tuning of the biological activity of functionalized polyelectrolyte multilayers. Adv. Funct. Mater. 2005, 15:648-654 (IF-10.439). 7. Benkirane-Jessel N et al., Multiple and time-scheduled in situ DNA delivery mediated by beta-cyclodextrin embedded in a polyelectrolyte multilayer. Proc Natl Acad Sci USA. 2006, 103:8618-8621 (IF-9.809). 8. Gangloff SC, Ladam G, Dupray V, Fukase K, Brandenburg K, Guenounou M, Schaaf P, Voegel J-C, Benkirane-Jessel N: Biologically active lipid A antagonist embedded in a multilayered polyelectrolyte architecture. Biomaterials. 2006, 27:1771-1777 (IF-8.312). 9. Dierich M, Le Guen E, Messadeq N, Netter P & Benkirane-Jessel N. Bone formation mediated by growth factors embedded in a polyelectrolyte multilayer film. Adv Mater 2007, 19: 693-697 (IF-15.409). 10. Nadiri A, Kuchler-Bopp S, Hu B, & Benkirane-Jessel N. Cells apoptosis Control by BMP-4 and Noggin embedded in a polyelectrolyte multilayer film. Small 2007, 3: 1577-1583 (IF-7.514). 11. Zhang X, Sharma KK, Boeglin M, Mainard D, Mély Y, Benkirane-Jessel N. Transfection ability and intracellular DNA pathway of nano-structured gene delivery systems. Nano Letters 2008, 8: 2432-2436 (IF-12.94). 12. Daubiné F, Cortial D, Ladam G, Atmani H, Clézardin P, Benkirane-Jessel N. Nanostructured polyelectrolyte multilayer drug delivery systems for bone metastasis prevention. Biomaterials 2009, 30: 6367-6373 (IF-8.312). 13. Grossin L, Cortial D, Saulnier B, Félix O, Decher G, Netter P, Gillet P, Mainard D, Benkirane-Jessel N. Step-by-step build-up of biologically active cell-containing stratified films aimed at tissue engineering. Adv Mater 2009, 21: 650-655 (IF-15.409). 14. Zhang X, Oulad-Abdelghani M, Zelkin AN, Wang Y, Mainard D, Caruso F, Benkirane-Jessel N. Poly(L-lysine) nanostructured particles for gene delivery and hormone stimulation. Biomaterials 2010, 31: 1699-1706 (IF-8.312). 15. Facca S, Cortez C, Mendoza-Palomares C, Messadeq N, Dierich A, Johnston APR, Mainard D, Voegel JC, Caruso F, Benkirane-Jessel N. Active multilayered capsules for in vivo bone formation. Proc Natl Acad Sci, 2010, 107, 3406-3411. (IF-9.809). 16. Florence Fioretti; Carlos Mendoza-Palomares; Marie Helms; Denise Al Alam; ludovic Richert; Youri Arntz; Simon Rinckenbach; Fabien Garnier; Youssef Haïkel; Sophie C Gangloff, Benkirane-Jessel N.Nanostructured assemblies for dental application. ACS Nano 2010, 4, 3277-87. (IF-12.033) 17. Facca S, Lahiri D, Fioretti F, Agarwal A, Benkirane-Jessel N, In vivo osseointegration of nano-designed composite coatings on titanium implants. ACS Nano 2011, 5: 4790-4799. (IF-12.033) 18. Mendoza-Palomares C, Ferrand A, Facca S, Fioretti F, Mainard D, Ladam G. Benkirane-Jessel N, Smart Hybrid Materials Equipped by Nanoreservoirs of Therapeutics. ACS Nano, 2012, 6, 483-490. (IF-12.033) 19. Eap S, Ferrand F, Schiavi J, Keller L, Fioretti F, Ladam G, Benkirane-Jessel N. Collagen implants equipped by “fishscale”- like nanoreservoirs of growth factors for bone regeneration. Nanomedicine. 2014, 9, 1253–1261. (IF-5.824) 20. Keller L, Schiavi J, De Isla-Martinez N, Morand D, Mainard D, Schwinté P, Benkirane-Jessel N. (2014). Active and nanostructured collagen implant reinforced with human mesenchymal stem cells microtissues for bone regenerative nanomedicine. Nanomedicine 2015. (In press) Invited talks and plenary sessions at different countries: USA, Venezuela, Italy, Japan, Spain, India, China, Canada, Morocco, Australia, Israel, Website: http://www.regmed.fr/ http://cvscience.aviesan.fr/cv/862/nadia-benkirane-jessel http://www.linkedin.com/pub/nadia-benkirane-jessel/24/39b/345

Molecular and cellular biology, immunochemistry, tissue engineering and biomedical engineering. In the last 10 years, she focused her research on the bio-functionalization of multilayered polyelectrolyte architectures with emphasis on the use of these architectures to induce specific cellular responses and gain control over cell proliferation and differentiation.

Privat Dozent Dr. habil. Yogendra Kumar Mishra is working as Group Leader at Functional Nanomaterials, Institute for Materials Science, Kiel University, Germany, After Ph. D. in 2008 in Condensed Matter Physics from JNU New Delhi, India, he migrated to work at Functional Nanomaterials group Kiel with the prestigious Alexander von Humboldt Postdoc Fellowship award (Feb. 2009 to Feb. 2011) where he continued working till today. Recently in 2015, he finished his Habilitation degree (Venia Legendi) in Materials Science from Kiel University and currently leading a sub-group on 3D Nanomaterials at Functional Nanomaterials. In Kiel, he introduced a new fabrication technique known as 'Flame Transport Synthesis-FTS' which offers versatile (1D to 3D) nanostructuring of different metal oxides including their three-dimensional (3D) interconnected ceramic nano-networks. His main research focus is the growth of highly porous and mechanically flexible 3D interconnected materials built from ZnO nano- and microtetrapods by FTS approach which could be used as next generation 3D flexible semiconducting ceramics for advanced technologies or as sacrificial templates for fabrication of new 3D nanomaterials including hybrids. His recent research developments include growth of carbon based ultra-light Aerographite material, Aerographite-GaN hybrid 3D networks, ZnO tetrapods network based devices, ZnO networks as viral traps, SnO2 nanowire based stretchable ceramic materials for UV sensing, alongwith several other applications. He has published more than 80 papers in high rank international magazines. He is referee for many prestigious peer-reviewed magazines and also serves as an Editorial Board Member in Nature-Scientific Reports, as an Academic Editor in PLoS ONE, including Advisory Board Members in several international conferences.

His main research focus is the growth of highly porous and mechanically flexible 3D interconnected materials built from ZnO nano- and microtetrapods by FTS approach which could be used as next generation 3D flexible semiconducting ceramics for advanced technologies or as sacrificial templates for fabrication of new 3D nanomaterials including hybrids. His recent research developments include growth of carbon based ultra-light Aerographite material, Aerographite-GaN hybrid 3D networks, ZnO tetrapods network based devices, ZnO networks as viral traps, SnO2 nanowire based stretchable ceramic materials for UV sensing, alongwith several other applications.

Julio San Roman has completed his Doctor in Chemistry (Polymers Science) in 1975 and currently heads the Group of Biomaterials, Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Cientificas, CSIC at Madrid, Spain. He is a Full Professor in the Consejo Superior de Investigaciones Cientificas and a Member of the European Society for Biomaterials ESB, since 1987 and of the Council of the Society since 2006. He is the Fellow of the Biomaterials Societies since 2004. He held the president position of Iberian Society for Biomechanics and Biomaterials, Polymer Section of the Spanish Royal Society of Chemistry and European Polymer Federation. He has been a member of the Scientific Committee of ESB meetings in the last 10 years adn the chairman of the European Polymer Congress EPF 2011 organised in Granada, Spain, and chairman of the 2013 congress of the European Society for Biomaterials organised in Madrid, Spain. The Scientific activities are centred in the study and development of polymer systems for biomedical applications, and specifically in Tissue Engineering, Polymer Drugs and Drug Delivery Systems. He has published more than 400 refereed articles in specialised journals of Polymer Science, Biomaterials, and the Biomedical field. He has contributed with more than 40 Chapters in specialised books and is co-editor of two books on biodegradable polymers for biomedical applications and Biomaterials.

Biomaterials, Hydrogels, Biopolymers, Tissue engineering

Dr Abbas Amini is an associate lecturer, a registered member of Western Sydney University graduate supervisory board at the School of Computing, Engineering and Mathematics, and the member of Work Health and Safety Committee of the same university, Penrith Campus. Before joining the Western Sydney University, he conducted research with other Australian universities and CSIRO, as a postdoctoral research fellow at Monash University and Deakin University, and as a senior research fellow at the University of Melbourne. His fine outcomes have been presented in high impact factor journals, e.g., Nature publication group, and a recent published book in 2016. Abbas started his teaching, industrial and scientific journey from obtaining an associate’s degree in mathematics, and BSc, MSc, and PhD (from the Hong Kong University of Science and Technology) in mechanical engineering and nanotechnology. Since then, he has updated himself with several Australian and Canadian nationally recognized professional certificates and diplomas, e.g., FULT (Foundations of University Learning and Teaching form Western Sydney University), TAE, WHS, CNC etc. With his intense schedule, he has been extensively involved in teaching for many years in different sectors (including Western Sydney University), and worked in industry, e.g., Magna Powertrain, Toronto, Canada, as an engineer and industrial designer. Dr Amini is a member of American Society of Mechanical Engineers (ASME), an editor of more than ten journals, and a committee member of 14 international conferences to-date. In academic supervisory assignments, Abbas is supervising four PhD and two MSc graduate students, at present.

indentation methods, shape memory alloys, water treatment, drug delivery systems, piezoelectric materials, biomedical materials, graphene, graphane, CNTs, biodegradable polymeric nano-composites, TiO2, ZnO, environmental sustainability and water efficiency, experimental analysis, multi-scale (nano to macro) modelling of multi-physics phenomena, phase transition, mechanics of materials, fabrication of modern composites, manufacturing, offshore naval structures, and ship design.

Prof. Dr. Aleksandra Lobnik is since 2009 a Full professor at the Faculty of Mechanical Engineering at the University of Maribor, where she teaches chemistry, analytical chemistry, and nanomaterials courses. The focus of Aleksandra Lobnik’s research is the development of new optical chemical and bio-sensors for different applications, such as personal protection, security, smart textiles, environmental protection, food, medicine. The emphasis is on the synthesis of new materials, nanomaterials, biomaterials, and sol-gels, which would improve sensory characteristics. In 2006 she co-founded a spin-off company IOS Ltd, where she is also employed. She is currently most involved in applicability of scientific research in the field of sensors, nanomaterials and water treatment. In the meantime, she strongly intensified cooperation with various Slovenian and foreign companies. Aleksandra Lobnik is also active in the promotion of science, because she is regularly invited to various committees and gives a wide range of interviews on the topic of nano-sciences and knowledge transfer in real applications in widely accessible media such as television, daily newspapers and magazines. In 2015 she lectured at TEDx in CERN on the topic of sensors. (http://tedxcern.web.cern.ch/video/2015/nanosensors-love-and-other-emotions).

The focus of Aleksandra Lobnik’s research is the development of new optical chemical and bio-sensors for different applications, such as personal protection, security, smart textiles, environmental protection, food, medicine. The emphasis is on the synthesis of new materials, nanomaterials, biomaterials, and sol-gels, which would improve sensory characteristics.

Theodore Eliades graduated from the School of Dentistry, University of Athens, Greece, and completed the Orthodontic postgraduate program of the Ohio State University earning a Master’s as well as a doctorate from the University of Athens, School of Medicine, and a PhD from the University of Manchester,UK; he has also obtained certificates in human resources management (Univ. of Athens), leadership management, cultural integration management (NLP), and management (Swiss management center). His research has generated over 170 papers and 35 book chapters, which have received 4700 citations (H index 38). He has edited 9 textbooks published by major houses, some translated into 5 language. An elected Fellow of the Institute of Materials, Minerals and Mining, and the Royal Society of Medicine, Prof. Eliades is the first dentist who was awarded the Fellowship grade of membership from both the Royal Society of Chemistry, and the Institute of Physics. He is affiliated with institutions in the US and Europe (Texas, Marquette, Manchester and Bonn), is currently the editor-in-chief of the J Dent Biomec, Assoc.Editor of the Eur J Orthod, the Am J Orthod Dentofacial Orthop, and Progress Orthod, Editorial Board member in 6 and reviewer in 40 periodicals. He has served as a member of the task Force for harmonization of worldwide postgraduate orthodontic education of the World Federation of Orthodontists and the revised Erasmus guidelines committee for postgraduate orthodontic education in Europe.

Enamel-adhesive interfacial phenomena and alterations during orthodontic treatment (structure, roughness, color, gloss). In vivo-ageing of orthodontic materials by means of surface analysis (Auger and ESCA, EDX and SEM) as well as mechanical properties of used dental and biomedical materials with associated clinical implications in bonding and mechanotherapy. Clinical trials assessing the efficiency of orthodontic materials. Development and testing of new adhesives based on non-Bis-GMA containing monomer systems (degree of conversion, bond strength monomer leaching). Corrosion potential and ionic release of alloys and leaching of polymeric materials in the oral environment. BPA release and estrogenicity of polymers. Mechanics of materials (strength, fatigue, bond strength) and tissues with reference to PDL properties in health, disease and developmental/ageing status.

José Becerra (J. Becerra) graduated and PhD (1976) in Biological Sciences at the University of Granada, Spain. He is full professor of Cell Biology at the University of Malaga (UMA) since 1989. He has been the dean of the Faculty of Sciences (UMA) (1986-93) and has been the head of the Department of Cell Biology, Genetics and Physiology (1994-2016). He promoted and directed (2001-03) the Andalusian Center of Developmental Biology (CABD). He has also been part of the Technical Commission of the National Bank of Cell Lines (2006-12), a member of the board of the FIMABIS Foundation (2005-12), part of the Science Commission from the ANECA for the evaluation of full professor candidates (2007-11), and part of the Steering Committee, coordinator of the Biomaterials and Tissue Engineering Branch (2011-15) and deputy director (from 2015) of the Ciber-bbn. He is also Vice-president of the Academy of Science of Malaga. Since March 2014 he is the scientific director of The Andalusian Centre for Nanomedicine and Biotechnology, BIONAND (http://www.bionand.es/). His scientific career includes extended stays in the Centro de Investigaciones Biológicas (CIB, CSIC) (Madrid, Spain), the Neuropathology Institute of the Freie Universität Berlin (Germany), the School of Medicine at the Universidade de Sao Paulo (Brazil) and the Children´s Hospital of the University of Southern California (USC) (Los Angeles, EEUU). Additionally he has also been visiting professor at the USC. His current research interests are focused on the study of the cellular and molecular mechanisms of tissue regeneration and the translation of such knowledge to the human clinics through cartilage and bone tissue engineering. In his laboratory, therapeutic tools based on mesenchymal stem cells, recombinant proteins with specific molecular domains (bFGF, BMP-2 and BMP-6), biomimetic peptides and micro- and nanostructured biomaterials for osteo- and chondrogenesis based on collagen, ceramics, polymers and titanium are currently being developed. He is the author 120 scientific articles and inventor of seven registered patents. He is the principal investigator (PI) of several research grants and contracts with private companies, PI of the Bioengineering and Tissue Regeneration Lab (LABRET). His research group is a member of the Cell Therapy Network (TerCel) and of the Ciber-bbn (Instituto de Salud Carlos III, Madrid).

Cellular and moledcular mechanisms of tissue regeneration,cartilage and bone tissue engineering, mesenchymal stem cells, nanostructured biomaterials for osteo-and chondrogenesis based on polymers, composites,collagen and titanium.

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine and Director of Nanotechnology and Regenerative Medicine Company has worked at Royal Free Hospital and University College London over 25 years, published over 647 peer-reviewed research papers, edited 2 books and contributed to 39 book chapter, and 14 UK and International patents. He is currently director of NanoRegMed Ltd, working in commercialisation of his research. During his career he has led and managed many large projects with multidisciplinary teams with very successful outcomes in terms of commercialisation and translation to patients including 1) The development and commercialisation of a bypass graft for vascular access for haemodialysis; 2) The development of bioreactors with fluid dynamic systems; 3) Non-invasive techniques to monitor viscoelastic properties of cardiovascular system and many others. He was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade & Investment (UKTI) in the Life Sciences and Healthcare category. European Life Science Awards. Winner of most innovative new product 2012 “Synthetic Trachea”. Hamburg, Germany, 29 may 2012. He also was awarded Nanosmat Prize in August 2013 in Spain for his achievements and contributions to Nanoscience and nanotechnology. In 2016 in Brussels he received the Heals distinguish research award in recognition for his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. He developed world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials and bioactive molecules and stem cells technology. He has created a huge amount of media interest for his translational research work to first in man, including; world first synthetic trachea, bypass graft, lacrimal duct, and other surgical implants.

Development of Nanomaterial,cardiovascular implant,nanofluorescence particle including quantum dots for localisation and treatment of cancer,Stem cells for development of organ using tissue engineering. Development of organ using biodegradation nanomaterials and stem cells, including liver, intestine,Hepatic microcirculation and oxygenation using optical technique,Ischemia reperfusion injury and preconditioning.

Piedad N de Aza studied Chemistry at the Autonoma University of Madrid and Ceramic at the Santiago de Compostela University where she received her PhD. She did a postdoctoral stage at the IRC in Biomaterials at the Queen Mary & Westfield College, University of London (U.K.) working on in vitro and in vivo behavior of bioceramics. At this moment, she is the Head of the Materials Science, Optic and Electronic Technology Department, Professor of Materials Science and Metallurgical Engineering and Researcher in the Bioengineering Institute at the Miguel Hernandez de Elche University.

Design and developing new polycrystalline biomaterials (dense and porous) with controlled microstructures making use of appropriated phase equilibrium diagrams and to study, a part of their physical properties, their behaviour in vitro (stem cells) and in vivo (bioactivity in rats and dogs). Actually, main emphasis is putting on the tissue engineering field study of the tissue-ceramic implant interfaces

IVAN CHODAK Affiliation : Polymer Institute of the Slovak Academy of Sciences Job status : Senior scientist Department of Composite Materials Full Professor of Macromolecular Science, Slovak Technical University Education and Professional carreer : 1960 - 1965 Slovak Technical University, Faculty of Chemical Technology, Bratislava 1965 - 1970 Matador, rubber factory, Bratislava 1970 - Polymer Institute, Slovak Acad. Aci., BRATISLAVA 1970 - 1973 PhD Student 1975 PhD 1973 - 1981 Scientist 1982 - 2010 Head of Department of Composite Thermoplastics 1989 – 1990 Deputy Director 1997 DSc 2000 Associated Professor of Macromolecular Science 2005-2009 Member of Presidium of the Slovak Academy of Sciences 2006 Full professor of Macromolecular Science LEAVES OF ABSENCE 1981 - 1982 One-year sabbatical leave at Clarkson University, Potsdam, NY 1983 - 1997 Several short-term stays (up to two months), e.g. Techn. Univ. Eindhoven, Univ. Quebec Trois Rivieres, ENSAM Paris, CNR Arco Felice, etc. AWARDS 1989 - Slovak National Prize for excellent results in polypropylene modification (member of a team of 5 scientists) 1993 - Silver Medal of Dionýz Štúr for "A Significant Contribution to a Development of Natural Sciences" 2003 – Medal of Slovak Academy of Sciences for Achievements in Science 2012 – Award of the Minister of Education of Slovak Republic as the Scientific Personality of the Year 2014 – Gold Medal of the Slovak Academy of Sciences Scientific interests Multiphase systems with a modified polymeric matrix, synthesis and properties. Crosslinking of polymers, especially polyolefins and rubbers. Nanocomposites with polymeric matrices, special experience with matrices of biodegradable plastics and rubbers. Modification of biodegradable plastics, physical, chemical, blending Electroconductive polymeric composites Papers : More than 150 papers in peer reviewed international scientific journals (mainly CC), 8 chapters in monographies, about 100 lectures in scientific conferences (including about 30 invited key and plenary lectures), 12 slovak patents, 3 European patents Around 1300 citations, Hirsch index 17 International cooperation Extensive international cooperation with universities (Eindhoven, Dresden, Free State University South Africa, Univ Quebec Trois Rivieres, Canada) and with companies on contract basis (Matador-SK, DSM - NL, National Power - UK, GE Plastics - NL, Biomer – Germany, etc., including number of local SMEs) A member of Editorial Board of Plasty a kaucuk (Plastics and Rubber), Czech republic, member of Editorial board of Bentham Open Macromolecular Journal Teaching 15 years teaching the courses on Polymer Physics at Slovak Technical University, Faculty of Chemcial and Food technology, Bratislava as well as at Trencin University, Faculty of Industrial Technologies, Puchov

Multiphase systems with a modified polymeric matrix, synthesis and properties. Crosslinking of polymers, especially polyolefins and rubbers. Nanocomposites with polymeric matrices, special experience with matrices of biodegradable plastics and rubbers. Modification of biodegradable plastics, physical, chemical, blending Electroconductive polymeric composites

Professor Nicolas Voelcker. After completing his BSc at the University of Saarland (1993) and his MSc at the RWTH Aachen (1995) in Germany, Nico completed a PhD thesis (1999) in polymer surface chemistry at the DWI Leibniz Institute for Interactive Materials under Professor Hartwig Höcker. He received postdoctoral fellowships to work in the area of bioorganic chemistry under Professor Reza Ghadiri at the Scripps Research Institute in La Jolla, California. In 2001 he became a Lecturer at Flinders University in Australia, an Associate Professor in 2006 and a full Professor in 2008. From 2008-2011, he was the Associate Head of the Faculty of Science and Engineering at Flinders University. Since 2012, he is a Professor in Chemistry and Materials Science at the Mawson Institute of the University of South Australia. From 2013-2015, he was Deputy Director of the Mawson Institute at the University of South Australia and Program Leader of the Cooperate Research Centre for Cell Therapy Manufacturing. Since 2014, he is also Node Leader in the Australian Research Council Centre of Excellence in Convergent Bio-Nano Science & Technology. In 2017, he will take up the role of Director of the Melbourne Centre for Nanofabrication and Professor at the Monash Institute of Pharmaceutical Sciences at Monash University. His key research interest lies in the fabrication and surface modification of porous semiconductor materials for applications in biosensors, biochips, biomaterials and drug delivery. A core research activity in his laboratory is the study of porous silicon based nanostructures and their surface chemistry. A current focus is the development of new nanostructured materials for biosensors, biochips, biomaterials and drug delivery. He has authored over 300 peer-reviewed journal articles with over 5600 citations, h-index 41. He has received fellowships from the German Research Foundation (DFG), the CSIRO, the Alexander von Humboldt Foundation, is a recipient of the Tall Poppy Science Award, a finalist for the South Australian Scientist of the Year 2015 and the Australian Innovation Challenge. He is serving on the College of Experts of the Australian Research Council.

His key research interest lies in the fabrication and surface modification of porous semiconductor materials for applications in biosensors, biochips, biomaterials and drug delivery. A core research activity in his laboratory is the study of porous silicon based nanostructures and their surface chemistry. A current focus is the development of new nanostructured materials for biosensors, biochips, biomaterials and drug delivery.

Sergey V. Dorozhkin completed his Ph,D in inorganic chemistry and chemical technology in 1992 and post-doctoral fellowship on the surface nucleation, solid/liquid interface and biomineralization during 1996-1997 at Strasbourg University (France) and on calcium phosphate based biomaterials and bioresorbable organic-inorganic composites during 1997-1998 at Nantes University (France). He has also held industrial positions in many companies. He is the author of more than 160 articles on different areas related to biomaterials, bioceramics etc.

Biomaterials, Bioceramics , Mechanical Properties of Biomaterials, Apatite, Calcium Phosphates, Biomineralization, Inorganic Materials and Surface Chemistry, Bone Cements, Fundamentals of Dental Caries, Dental Erosion and Vascular Calcification, Simulated Body Fluid (SBF), Porous Bioresorbable Scaffolds, Industrial Production of Biomaterials and Bioceramics, Organic-Inorganic Composites and Hybrid Biomaterials, Tissue Engineering, Phosphoric Acid and Chemical Engineering.

Gordon Blunn is a bio-engineer at the Institute of Orthopedics and Musculoskeletal Science at University College London; he is based at the Royal National Orthopedic Hospital. He has been at this Institution for 25 years and during this period of time he has investigated the use of the fixation of implants to the skeleton. He has translated a number of novel treatments and designs into patients, which has enhanced implant fixation. He is currently the president of the British Orthopedic Research Society. Over the last 5 years he has secured in excess of £3.6 million in funding, holds the position of Chief Scientific Officer for Stanmore Implants Worldwide Ltd. and is co-director of the London Implant Retrieval Centre (LIRC). He has extensive research experience in orthopedic medical devices, materials and musculoskeletal tissues. A number of his research projects have been translated into clinical practice. He has worked on the reattachment of tendons to bone and to implant surfaces, the integration of implants with the skeleton, the wear of implant bearing materials and the use of bone graft substitute materials. Recently his research has focused on the design and development of implants, retrieval analysis and reconstruction of bone and joints. He has published over 150 papers in peer-reviewed journals; holds a number of patents on medical devices as well as being a scientific adviser to a number of SMEs.

Orthopaedic medical devices, Materials and Musculoskeletal tissues

Theodore Eliades graduated from the School of Dentistry, University of Athens, Greece, and completed the Orthodontic postgraduate program of the Ohio State University earning a Master’s as well as a doctorate from the University of Athens, School of Medicine, and a PhD from the University of Manchester,UK; he has also obtained certificates in human resources management (Univ. of Athens), leadership management, cultural integration management (NLP), and management (Swiss management center). His research has generated over 170 papers and 35 book chapters, which have received 4700 citations (H index 38). He has edited 9 textbooks published by major houses, some translated into 5 language. An elected Fellow of the Institute of Materials, Minerals and Mining, and the Royal Society of Medicine, Prof. Eliades is the first dentist who was awarded the Fellowship grade of membership from both the Royal Society of Chemistry, and the Institute of Physics. He is affiliated with institutions in the US and Europe (Texas, Marquette, Manchester and Bonn), is currently the editor-in-chief of the J Dent Biomec, Assoc.Editor of the Eur J Orthod, the Am J Orthod Dentofacial Orthop, and Progress Orthod, Editorial Board member in 6 and reviewer in 40 periodicals. He has served as a member of the task Force for harmonization of worldwide postgraduate orthodontic education of the World Federation of Orthodontists and the revised Erasmus guidelines committee for postgraduate orthodontic education in Europe.

Enamel-adhesive interfacial phenomena and alterations during orthodontic treatment (structure, roughness, color, gloss). In vivo-ageing of orthodontic materials by means of surface analysis (Auger and ESCA, EDX and SEM) as well as mechanical properties of used dental and biomedical materials with associated clinical implications in bonding and mechanotherapy. Clinical trials assessing the efficiency of orthodontic materials. Development and testing of new adhesives based on non-Bis-GMA containing monomer systems (degree of conversion, bond strength monomer leaching). Corrosion potential and ionic release of alloys and leaching of polymeric materials in the oral environment. BPA release and estrogenicity of polymers. Mechanics of materials (strength, fatigue, bond strength) and tissues with reference to PDL properties in health, disease and developmental/ageing status.

Andy Lewis completed his degree and PhD at Aston University. He spent his early career with ICI, working in the area of advanced polymer membranes and subsequently with Johnson & Johnson leading projects in absorbent technologies. Andy Lewis is Research & Technology Director for Biocompatibles UK Ltd, a UK-based SME involved in biomaterials development and medical device manufacture (now part of BTG). He specializes in the development of advanced biomedical polymer systems, for instance, to enhance the biocompatibility of implants or to modulate delivery of active agents in the body. These technologies have been applied to novel drug-device combination products for use in interventional therapies in the treatment of cardiovascular disease and cancer. He also coordinates the external research programmes with a number of academic collaborators and is named on over 60 scientific publications and patents in the fields of polymers and biomaterials. He has a BSc in Biochemistry & Chemistry, a PhD in Chemistry and is a Fellow of the Royal Society of Chemistry.

Polymeric Materials, Biomaterials, Biomaterial Engineering, Combination Products, Drug Delivery, Polymers, Embolisation, Biocompatibility, Cancer Therapy, Encapsulation, Polymer Chemistry, Biomimetics, Hydrogel, Polymerization, Biomaterial Science, Micelles

Dr. Fenniri was educated at the University of Louis Pasteur in Strasbourg, France, receiving his undergraduate degree in chemistry and biochemistry (1989, top of his class), and his M.Sc./Ph.D. degrees in supramolecular science and engineering (1990/1994) under the supervision of Professor Jean-Marie Lehn (Nobel Laureate). He then joined the Scripps Research Institute in California, USA, where he carried out his postdoctoral training under the supervision of Professor Richard A. Lerner (President and CEO). In 1997 he moved to Purdue University, where he initiated his independent academic career, and established the Purdue Laboratory for Chemical Nanotechnology (1999). In 2003, He joined the National Research Council and the University of Alberta to build and lead the Supramolecular Nanoscale Assembly program, and contribute to the shaping of the National Institute for Nanotechnology (NINT), its research programs and facilities, and the recruitment of highly qualified personnel. NINT has since grown from 4 principal investigators in 2003 to a vibrant research and technology organization of over 350 researchers in 2013.

In addition, Dr. Fenniri held a full professor position with the Department of Chemistry (since 2003-2013) and adjunct full professor positions with the department of biomedical engineering (since 2010) with the faculty of medicine, and with the department if Chemistry (since 2013) at the University of Alberta. Dr. Fenniri is currently Professor Chemical and Biomedical Engineering at Northeastern University, Boston, MA, USA.

Dr. Fenniri has achieved international recognition as a leader in the areas of self-assembly, supramolecular chemistry, nanomedicine, combinatorial chemistry, and materials sciences. His group works at the forefront of basic and applied nanosciences, in collaboration with various academic institutions, federal laboratories, and with the private sector. Dr. Fenniri’s contributions appeared in over 190 publications, 8 patents, and over 400 contributed national and international conference papers. Dr. Fenniri has also presented his work in over 150 invited distinguished lectures, colloquia and seminars around the globe. His research programs are supported by the Natural Science and Engineering Research Council of Canada, Alberta Advanced Education and Technology, the US National Institutes of Health, the National Research Council of Canada, the University of Alberta, and several private, provincial and federal funding organizations.

Dr. Fenniri is the recipient of several academic and professional honours and awards, including the Xerox UAC Award (2006–2008), the 3M Faculty Award (2000, 2002), the Showalter Trust Fund Award (1999, 2001), the Trask Trust Fund Technology Innovation Award (2000), the Cottrell Teacher Scholar Award (2000–2005), and the US National Science Foundation Career Award (1999–2003). Dr. Fenniri is Member of the Editorial Board of several scientific journals and serves on several national and international scientific boards, panels, and committees.

Dr. Fenniri has been an invited professor at the Université de Strasbourg and the Collège de France (2010), the National University of Taiwan (2007), and the University of Colorado Boulder, USA (2004). He has also been DAAD Visiting Professor at Regensburg University, Germany (2002, 2003).

Nanotechnology for biomedical applications, nanoscale materials for drug delivery, and cell therapeutics and regenerative medicine.

Professor Ramesh K. Agarwal is the William Palm Professor of Engineering and the director of Aerospace Engineering Program and Aerospace Research and Education Center at Washington University in St. Louis from 1994 to 200. He was the Sam Bloomfield Distinguished Professor and Executive Director of the National Institute for Aviation Research at Wichita State University. Dr. Agarwal received Ph.D in Aeronautical Sciences from Stanford University in 1975, M.S. in Aeronautical Engineering from the University of Minnesota in 1969 and B.S. in Mechanical Engineering from Indian Institute of Technology, Kharagpur, India in 1968. Professor Agarwal has worked in Computational Fluid Dynamics (CFD), renewable energy systems and nanotechnology. He is the author and coauthor of over 300 publications and serves on the editorial board of fifteen journals. Dr. Agarwal is a Fellow of fifteen societies including American Association for Advancement of Science (AAAS), American Institute of Aeronautics and Astronautics (AIAA), American Physical Society (APS), American Society of Mechanical Engineers, Society of Manufacturing Engineers (SME), Institute of Electrical and Electronics Engineers (IEEE), American Academy of Mechanics (AAM), and Institute of Physics. Astronautics (AIAA), American Physical Society

Nanomaterials, Carbon Nanostructures, Nanoparticles, Numerical Modeling and Simulation

Guillaume Saint-Pierre is a self-motivated R&D Program and project management professional and a material science group leader at a Madrid based private research center. He has significant years of experience, in related proficiencies and a background in roadmap development, product innovation and lifecycle leadership. He also has strong expertise (market, technical and legislative) in Medical devices (Class IIB, III), In-vitro diagnostic medical devices (IVD) and sensor technology for medical and environmental applications.

Medical devices (electrochemical actuators/diagnostic, drug combined combination products, implantable solution for cellular and acellular therapies), drug delivery device, encapsulation technology and material engineering in a broader definition (functional coatings, high performance fibers, smart packaging, biotransformation, air/water treatment solutions)

Julio San Roman has completed his Doctor in Chemistry (Polymers Science) in 1975 and currently heads the Group of Biomaterials, Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Cientificas, CSIC at Madrid, Spain. He is a Full Professor in the Consejo Superior de Investigaciones Cientificas and a Member of the European Society for Biomaterials ESB, since 1987 and of the Council of the Society since 2006. He is the Fellow of the Biomaterials Societies since 2004. He held the president position of Iberian Society for Biomechanics and Biomaterials, Polymer Section of the Spanish Royal Society of Chemistry and European Polymer Federation. He has been a member of the Scientific Committee of ESB meetings in the last 10 years adn the chairman of the European Polymer Congress EPF 2011 organised in Granada, Spain, and chairman of the 2013 congress of the European Society for Biomaterials organised in Madrid, Spain. The Scientific activities are centred in the study and development of polymer systems for biomedical applications, and specifically in Tissue Engineering, Polymer Drugs and Drug Delivery Systems. He has published more than 400 refereed articles in specialised journals of Polymer Science, Biomaterials, and the Biomedical field. He has contributed with more than 40 Chapters in specialised books and is co-editor of two books on biodegradable polymers for biomedical applications and Biomaterials.

Biomaterials, Hydrogels, Biopolymers, Tissue engineering,

Sandeep K. Vashist is the Head of Immunodiagnostics at Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. (HSG-IMIT) and Laboratory for MEMS Applications, Department of Microsystems Engineering (IMTEK) at University of Freiburg, Germany. He was the Bioanalytical Scientist at Bristol-Myers Squibb Company, Dublin, Ireland (2006-2009) and the Team Leader at NUS Nanoscience and Nanotechnology Institute, Singapore (2009-2012) after completing his Ph.D. from Central Scientific Instruments Organisation, India (2006). He pioneered and transferred successfully many technologies to industries and healthcare; filed several patents; and, published extensively (>100 manuscripts) in high IF journals and highly prestigious conferences. Based on his research outputs, he has been constantly awarded by renowned institutions for scientific research excellence, innovation and performance; received the topmost international research fellowships; and, awarded the invited memberships of societies such as RCS. He is the international expert reviewer for ~36 scientific journals (IF b/w 2.5-41) and numerous funding agencies; Executive Editor of J Basic Appl Sci and J Pharma Bioanal Sci; and Editorial Board member of J Nanomed Nanotech. His research interests are in the fields of nanotechnology, point-of-care devices, immunodiagnostics and biosensors.

Development of Nanomaterials/Nanotechnology based Biosensors and Diagnostics; Development of rapid immunodiagnostic kits using lab-on-a-chip platforms; Biomolecular immobilization and surface modification strategies; Signal enhancement using nanomaterials/polymers/design of platforms; Development of cost-effective and simple bioanalytical procedures; Bioanalytical sciences; Diabetic monitoring and screening; Nanomedicine and Nanotoxicity.

Mr. Bastianelli started his career in the Pathology Department of the Erasme University Hospital in Belgium. He joined Procter & Gamble Pharmaceuticals in 1996, where he was involved in the marketing of drugs in the field of bone diseases. In 1999, he became a consultant for McKinsey & Co, where he was involved in strategic and organizational missions for major pharmaceutical as well as biotechnology companies. From 2002 until mid-2006, Mr. Bastianelli worked as VP Corporate Development for ProSkelia, focused on bone diseases and hormone disorders. He was responsible for the management of the R&D portfolio, resources allocation and planning, alliances, collaborations and downstream integration. He was one of the main contributors to the merger with Strakan. Enrico Bastianelli has been CEO of Bone Therapeutics since 2006.

Orthopedic materials, Biomaterials, bone diseases and hormone disorders

Sergey V. Dorozhkin completed his Ph,D in inorganic chemistry and chemical technology in 1992 and post-doctoral fellowship on the surface nucleation, solid/liquid interface and biomineralization during 1996-1997 at Strasbourg University (France) and on calcium phosphate based biomaterials and bioresorbable organic-inorganic composites during 1997-1998 at Nantes University (France). He has also held industrial positions in many companies. He is the author of more than 160 articles on different areas related to biomaterials, bioceramics etc.

Biomaterials, Bioceramics , Mechanical Properties of Biomaterials, Apatite, Calcium Phosphates, Biomineralization, Inorganic Materials and Surface Chemistry, Bone Cements, Fundamentals of Dental Caries, Dental Erosion and Vascular Calcification, Simulated Body Fluid (SBF), Porous Bioresorbable Scaffolds, Industrial Production of Biomaterials and Bioceramics, Organic-Inorganic Composites and Hybrid Biomaterials, Tissue Engineering, Phosphoric Acid and Chemical Engineering.

Esmaiel Jabbari is Professor of Chemical Engineering at University of South Carolina. He is internationally known for his work on synthesis and processing of biomimetic bioinspired materials for drug delivery and tissue engineering applications. He has published extensively in the areas of biomaterials, drug delivery, and tissue engineering. He has edited four books, published one encyclopedia entry, 18 book chapters, over 90 refereed journal papers, over 80 refereed conference proceedings, presented over 30 invited seminars, and more than 200 presentations at National and International conferences.

He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering AIMBE in 2013. He received the Berton Rahn research prize award in Orthopedic Research from the Arbeitsgemeinschaft für Osteosynthesefragen AO Foundation in 2012. In 2008 he received the Stephen B. Milam Research Award from the Oral and Maxillofacial Surgery Foundation for contribution to auto-inductive biomaterials for repair of maxillofacial and cranial tissues. He is the North America Editor of the Journal of Biomaterials and Tissue Engineering and serves on the Editorial Board of International Journal of Biomaterials and International Journal of Biomedical Nanoscience and Nanotechnology. He is a member of the Outstanding College Students of America, the New York Academy of Sciences, Who is Who in Engineering Education, and Who's Who in America. He is also a member of honorary engineering society Tau Beta Pi, Chemistry Society Phi Lambda Upsilon, and Research Society Sigma Xi.

Bioinspired materials, Skeletal tissue engineering, Multi‐scale composite materials, Self-assembled nanogels for growth factor delivery, Drug targeting to cancer stem cells, Stem cell encapsulation and delivery, Model gels to control cell microenvironment

Anand Ramamurthi is an Associate Professor of Molecular Medicine and Biomedical Engineering at the Cleveland Clinic with adjunct appointments at the University of Akron (Integrated Biosciences Program), and Case Western Reserve University (BME). He received his PhD in Chemical Engineering, from Oklahoma State University, Stillwater, OK in 1999 and subsequently was an American Heart Association postdoctoral fellow at the Lerner Research Institute of the Cleveland Clinic (1999-2001), where he developed novel, glycosaminoglycan (GAG)-based biomaterials for biomimetic tissue engineering of aortic heart valve replacements.

Prior to his appointment at the Cleveland Clinic in 2010, Dr. Ramamurthi was a tenured faculty in the Departments of Bioengineering at Clemson University and Regenerative Medicine and Cell Biology the Medical University of South Carolina, Charleston, SC. His research program focuses on enabling biomimetic regeneration and repair of extracellular matrix structures, specifically the poorly regenerated elastic matrix component, both in vitro, and in situ at sites of chronic matrix disruption (e.g., abdominal aortic aneurysms and pelvic organ prolapse). His research projects span cardiovascular tissue engineering, biomimetic vascular matrix assembly, GAG-based biomaterials for vascular endothelialization and matrix regenerative repair, mechanisms of matrix degeneration in abdominal aortic aneurysms (AAAs), directed matrix regenerative therapies for AAAs, vascular nanomedicine, stem cell -based matrix regenerative therapies, in vivo bioreactor systems for vascular tissue engineering.

He is a member of several international professional societies in the cardiovascular sciences, biomaterials, and tissue engineering fields, and is a Professional Member of the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology. He serves on several national committees such as that of the North American Vascular Biology Organization (NAVBO), on the editorial broad of several scientific journals in the field of Tissue Engineering, Regenerative Medicine, and Vascular Biomedicine, and actively reviews for the NIH, NSF, AHA, and nearly 30 journals including Tissue Engineering, Biomaterials, and Acta Biomaterialia. He serves on the external advisory board of the NIH-supported Center for Biomedical Research Excellence (COBRE) in Biomaterials for Tissue Regeneration (CBTR) in South Carolina, and on the Inventions Peer Review Committee of Cleveland Clinic Innovations, the commercialization wing of the Cleveland Clinic.

Anand has been an invited presenter at several national conferences and has chaired past conference symposia on the topic of directed elastic matrix regenerative repair. He has 50 peer-reviewed publications to date, numerous abstracts, proceedings, several book chapters, and approved and filed patents. His research has been funded by the NIH, AHA national and affiliate centers, NSF, and industry.

Vascular Tissue Engineering, Cardiovascular degenerative Medicine, Biomimetic Matrix Assembly, Elastin Pathology and Elastic Matrix Regenerative Repair, Therapies for Aortic Aneurysms, Blood-Material Compatibility, Glycosaminoglycan-Based Biomaterials, Stem Cells for Vascular Therapies

Dr. Murugan Ramalingam is Professor at the Centre for Stem Cell Research (a unit of the Institute for Stem Cell Biology and Regenerative Medicine-Bengaluru), Christian Medical College Campus, India. Concurrently he is Adjunct Professor at the Tohoku University, Japan. Prior to joining the CSCR, he was Associate Professor of Biomaterials and Tissue Engineering at the Institut National de la Santé et de la Recherche Médicale, Faculté de Chirurgie Dentaire, Université de Strasbourg, France. He has worked at the WPI Advanced Institute for Materials Research, Japan, as an Assistant Professor. He has also worked at the National Institute of Standards and Technology (NIST) and the National Institutes of Health (NIH), under the U.S. National Academies Associateship program. He received his Ph.D. in Biomaterials from the University of Madras. He has also undergone training in Ethical and Policy issues on Stem Cells from Harvard University, USA, and in Operations Management from the University of Illinois-Chicago.

His current research interests are focused on the development of multiphase biomedical materials, through conventional to nanotechnology to biomimetic approaches, microfabrication, cell patterning, stem cell differentiation, tissue engineering and drug delivery.He is the author of over 200 publications, including peer-reviewed journal papers, conference proceedings, book chapters, authored books, edited books, and patents relevant to biomaterials, stem cells, and tissue engineering. His current h-index is 24 with over 4400 citations. He has organized several international conferences and chaired Biomaterials, Nanobiotechnology, Stem Cells and Tissue Engineering sessions. He also serves as a board member of several international scientific and research committees in various public and private bodies and grant reviewer of various international funding agencies.

He serves on the editorial boards of multiple biomaterials and tissue engineering-related journals, including as the Editor-in-Chief of the Journal of Biomaterials and Tissue Engineering, the Journal of Bionanoscience and the American Journal of Stem Cell Research. He is a recipient of several prestigious fellowships and awards, including CSIR Fellowship (India), SMF Fellowship (Singapore), NRC National Academies Fellowship (USA), Nationale Professeur des Universités (France), Fellow of Institute of Nanotechnology (UK) and Fellow of Royal Society of Chemistry (UK).

Stem cell differentiation, Cell patterning, Interface tissue engineering, Biomaterials, Biomolecular delivery.

Min Sheu has received his Ph.D. in Bioengineering from University of Washington at Seattle, WA, USA. Since graduation, he has led several teams in R&D of various companies in the medical device industry, including AST Products, Boston Scientific Corp., Atrium Medical (acquired by Maquet Getinge Group) and Covidien (merged with Metronic). He has skillful experience in the development of medical devices, including drug eluting ureteral stents, drug coated stents, antimicrobial and antithrombogenic dialysis catheters, biocompatible flow diverters and vascular embolization implants. His primary expertise is in the development of Class III biomaterial implants, drug-device combination products and medical coatings, and he has over 12 issued and 16 pending US patents as well as 16 peer-reviewed publications in these areas. Recently, Dr. Sheu founded a new company in Taiwan, InnoCept Biomaterials, Inc., to develop novel biomaterial implants for vascular and cancer therapies. InnoCept was later acquired by Sunmax Biotechnology, Co., Ltd., a collagen-based medical device company in Taiwan. Currently, Dr. Sheu serves as the General Manager of Sunmax Biotechnology.

Biomaterials, medical devices, combination product and drug delivery; Surface coating technologies for medical device, drug delivery and tissue engineering; Wound healing and soft tissue repair; Vascular and tumor embolization

Ipsita Roy is a microbial biotechnologist with special expertise in bacterial-derived biodegradable polymers. She is currently a Reader at the School of Life Sciences, University of Westminster, London, UK. She was awarded the prestigious Inlaks Scholarship and the Overseas Research Students Award to study for her Ph.D. at the University of Cambridge. During her time at Cambridge she was awarded the Churchill College Scholarship, the Lundgren Scholarship, Leche Trust Scholarship and the Cambridge University Philosophical Society Fellowship Award. Her postdoctoral work was at the University of Minnesota, USA, at the Bioprocess Technology Institute, where she worked on fatty acid biosynthesis. She taught at the Indian Institute of Technology, India, for four years as an Assistant Professor. During this time she worked actively on the production of biodegradable polymers from Streptomyces. She has been at the University of Westminster since 2000 and leads the Applied Biotechnology Research Group.

Ipsita Roy’s group is currently focused on the production of novel Polyhydroxyalkanoates, PHAs, a family of biodegradable and biocompatible polymers produced by bacteria under nutrient limiting conditions. Her group has pioneered the production of PHAs from Gram positive bacteria such as Bacillus sp., which lack immunogenic properties and hence are highly suitable for medical applications. These include applications in the area of hard tissue engineering, soft tissue engineering, wound healing and drug delivery. She has published over 100 research papers in her area, chaired and organized sessions and presented her work at numerous international conferences. She is an editor of the Journal of Chemical Technology and Biotechnology (JCTB) and has edited an ‘In Focus’ Journal on Biodegradable Polymers, a special issue of the JCTB.

Currently she is editing another In Focus issue on ‘Drug Delivery’. She regularly reviews manuscripts for many journals including Biomaterials, Bio-macromolecules, Journal of the Royal Society Interface, Journal of Chemical Technology and Biotechnology, Journal of Applied Physics, Material Science and Engineering, Applied Microbiology and Biotechnology, Tissue Engineering, Antonie van Leeuwenhoek, Biotechnology Journal and Reactive and Functional Polymers. She is on the BBSRC, NSERC, Canada, FWF, Austria and NSFC, China, grant-reviewing panels and is the Vice Chair, Biotechnology section, SCI, London, UK. She has been appointed expert in the field of Materials Science and Engineering by the Italian Agency for the Evaluation of University and Research (ANVUR).She has also been appointed by the European Research Council Executive Agency, "ERCEA" to the panel involved in the peer review evaluation of proposals.

Tissue engineering, Drug delivery, Molecular Enzymology, Quorum sensing, Elicitation, Bacterial metabolism, Fungal interactions, Carbohydrate biochemistry and Nanobiotechnology